Patents by Inventor Maoxing Yue

Maoxing Yue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for promoting nerve injury restoration and application thereof
    Patent number: 10537540
    Abstract: A pharmaceutical composition for promoting nerve injury restoration and a use thereof are disclosed. Each unit of the pharmaceutical composition contains 0.5 to 8 g of L-ornithine, 1 to 5 g of aspartic acid, 3 to 10 g of arginine and 3 to 10 g of vitamin B6. The pharmaceutical composition can significantly promote recovery of the spinal nerve function, and particularly has a good therapeutic effect on acute myelitis.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: January 21, 2020
    Inventors: Maoxing Yue, Honggui Wan, Tongge Huang
  • HYPOLIPIDEMIC COMPOSITION AND USE THEREOF
    Publication number: 20180028543
    Abstract: A composition has ornithine, aspartic acid and vitamin B6, and it is used in preparation of hypolipidemic drugs, health-care products, foods or food additives.
    Type: Application
    Filed: July 2, 2015
    Publication date: February 1, 2018
    Inventors: Honggui WAN, Maoxing YUE
  • PHARMACEUTICAL COMPOSITION FOR PROMOTING NERVE INJURY RESTORATION AND APPLICATION THEREOF
    Publication number: 20150335627
    Abstract: A pharmaceutical composition for promoting nerve injury restoration and a use thereof are disclosed. Each unit of the pharmaceutical composition contains 0.5 to 8 g of L-ornithine, 1 to 5 g of aspartic acid, 3 to 10 g of arginine and 3 to 10 g of vitamin B6. The pharmaceutical composition can significantly promote recovery of the spinal nerve function, and particularly has a good therapeutic effect on acute myelitis.
    Type: Application
    Filed: August 23, 2012
    Publication date: November 26, 2015
    Inventors: Maoxing YUE, Honggui WAN, Tongge HUANG
  • Pharmaceutical composition for treating coagulation disorder hemorrhage and method using the same
    Patent number: 8952040
    Abstract: Pharmaceutical composition for treating coagulation disorder hemorrhage. The pharmaceutical composition comprises (per unit): L-ornithine 0.5˜8 g, aspartic acid 1˜5 g, arginine 3˜10 g and vitamin B6 3˜10 g. A method of administrating the pharmaceutical composition to treat hemorrhage patients caused by coagulation dysfunction, especially critically ill patients.
    Type: Grant
    Filed: December 10, 2010
    Date of Patent: February 10, 2015
    Inventors: Maoxing Yue, Honggui Wan, Tongge Huang
  • PHARMACEUTICAL COMPOSITION FOR TREATING COAGULATION DISORDER HEMORRHAGE AND METHOD USING THE SAME
    Publication number: 20130143836
    Abstract: Pharmaceutical composition for treating hemorrhage caused by blood clotting disorder and use thereof. The pharmaceutical composition comprises (per unit): L-ornithine 0.5-8 g, aspartic acid 1-5 g, arginine 3-10 g and vitamin B6 3-10 g. The pharmaceutical composition can treat hemorrhage caused by blood clotting disorder effectively and is very appropriate for treating patient at stake.
    Type: Application
    Filed: December 10, 2010
    Publication date: June 6, 2013
    Inventors: Maoxing Yue, Honggui Wan, Tongge Huang